While genetic testing for the FBN1 gene, as suggested by the Ghent criteria, improves the likelihood of diagnosing MFS, it is insufficient for ruling out other Marfan-like connective tissue disorders. This evidence concerns the gene FBN1 and connective tissue disorder.